Abstract
Introduction
Alcoholism is one of the most widespread psychiatric disorders in Western countries. Current treatment services only partially meet patients needs. In a comprehensive review of alcohol treatment, McCrady and Langenbucher [1996] concluded that a reformed health care system should include full benefits for outpatient care which can be considered as an important task of community medicine. But the issue of outpatient detoxification is still controversial with most patients being treated in hospi-tals, at least in Germany and most other European countries. While favorable results of outpatient or day-hospital rehabilitation programs for substance use have been reported by Cornwall and Blood [1998] , McKay et al. [1995 McKay et al. [ , 1998 ], Ehrenreich et al. [2000] and Willenbring et al. [1995] , among others, outpatient detoxification is still a widely neglected issue in alcohol therapy [Fiellin et al., 2000; Prater et al., 1999] . Wiseman et al. [1998] reported that 85% of 108 patients enrolled in an outpatient detoxification program successfully completed detoxification without medical complications. Using a symptom-triggered pharmacological treatment approach, only 38% of patients received medication (chlordiazepoxide). In another sample of 577 patients consecutively referred to an ambulatory detoxification program, 453 completed outpatient detoxification [Wiseman et al., 1997] . Similarly Collins et al. [1990] reported a 79% completion rate in a sample of 76 patients using a fixed-dose regime. Patients had initially received 30-40 mg diazepam with gradual withdrawal over a 5-to 7-day period. Little is known about the mid-to long-term effects of outpatient alcohol detoxification. Collins et al. [1990] speculated that there were no particular reasons why outpatient detoxification should have any greater or lesser effect on long-term outcome than inpatient treatment, but currently there are few studies to support that notion.
Psychotherapeutic interventions are of great relevance for further treatment outcome. Current therapy recommendations suggest integrating psychotherapeutic 'motivational' elements into the detoxification period to motivate the patient for further therapy and abstinence [Feuerlein et al., 1998; John, 1991; John et al., 2000] . Based on the concepts of Rollnick [1991, 1999] , motivational techniques today are integrated into the detoxification phase [Feuerlein et al., 1998 ]. In Germany the integration of motivational aspects into detoxification is named 'qualified detoxification' (qualifizierte Entgiftung) [Mann, 2002] . A number of different motivational approaches varying in their intensity have been integrated into the early intervention or detoxification of alcoholics [John, 1991; John et al., 2000] . A major aim of motivational therapy during detoxification is to increase the patients own activity towards further therapy and into the 'action phase' according to the concept of Rollnick [1991, 1999] . In Germany the efficacy of 1-to 3-week motivational therapy during inpatient detoxification has been studied [John, 1991; Schwoon, 1990] but similar interventions during outpatient detoxification have not been the subject of research.
We report data of a psychotherapy-oriented alcohol outpatient program which was supported as a model project by major health insurances. This article describes the methods of the program and offers results on feasibility and outcome. Following the implementation of a structured outpatient detoxification program in an outpatient clinic, a prospective 1-year evaluation study on the applicability of this program and clinical outcome of the patients was performed.
Subjects and Methods
This was an open, prospective study to examine the implementation efficacy, medical safety and practicability of outpatient detoxification of alcohol-dependent patients.
The major aims of the study were to evaluate: (1) the acceptance and efficacy of outpatient alcohol detoxification; (2) the number of patients screened and included; (3) the number of patients successfully detoxified, and (4) the medical complications.
The efficacy of the concomitant psychotherapeutic approach was also evaluated. Patients were examined 12 months after detoxification to assess whether (1) they had completed the consecutive 1-year outpatient rehabilitation program for alcohol dependence, and (2) were abstinent or had relapsed at follow-up.
Inclusion Criteria
Patients had to meet ICD-10 [Dilling et al., 1994] and DSM-IV [American Psychiatric Association, 1994] criteria for alcohol dependence. Patients were requested to be willing to participate in an outpatient treatment and detoxification for alcohol dependence. Also one close relative (spouse, etc.) or friend was required as support for the patient at home (not mandatory).
Exclusion Criteria
Polysubstance use, history of severe alcohol-related disorders (seizures, alcohol psychosis), major psychiatric disorders (e.g. schizophrenia, suicidality), severe cognitive deficits, severe medical disorders (pneumonia, tuberculosis or other infectious diseases), head injury, severe liver cirrhosis, erosive gastritis, pancreatitis, reduced physical state and cardiovascular disorders were reasons for exclusion.
Treatment Facility
The treatment facility is an outpatient clinic (Klientenzentrierte Problemberatung Dachau, KPB, Fachambulanz für Suchterkrankungen) specialized in the treatment of substance use disorders which offers a comprehensive two-step rehabilitation model for alcohol dependence: A 3-month motivational treatment phase was followed by a 6-to 9-(mean 8)-month rehabilitation program (80-120 group and individual therapy sessions). The motivational phase is usually paid for by the health insurers, the rehabilitation phase by pension funds.
Details of the program have been described elsewhere [Soyka et al., 1997 [Soyka et al., , 2002 .
Motivational Phase
The motivational phase starts immediately after outpatient detoxification. During the motivational phase patients are seen several Soyka/Horak times a week. An extensive internal/neurological examination and a detailed psychodiagnostic examination are performed. The weekly setting during the motivational phase consists of a 'motivationalenhancement group' (cognitive-oriented therapy, including Jacobson progressive muscular relaxation) and a so-called 'support group' (body and emotional-oriented therapy, autogenic training) and four individual psychotherapy/medical sessions.
Rehabilitation Phase
The therapeutic concept is integrative and eclectic, and includes different psychotherapeutic methods and approaches.
The therapy program comprises 80 to maximum 120 therapy sessions, mostly group therapy but also individual therapy, including behavioral/cognitive, psychodynamic and systemic oriented therapy sessions. Optional elements are self-help groups, but also other elements such as psychodrama or muscular relaxation, among others, are also used.
During the entire treatment abstinence is checked by repeated breathalyzer tests as well as blood laboratory tests. The therapeutic team comprise 2-3 psychiatrists (physicians), 2 full-time psychotherapists, several part-time psychologists, and 1 social worker. As for inpatient treatment clinical coworkers of the outpatient clinic must fulfill qualifications to be acknowledged by pension funds as therapists.
The outcome of the rehabilitation program has been the subject of research before. An earlier retrospective follow-up study had revealed a 46% abstinence rate 18 months after treatment [Soyka et al., 1997] ; a prospective 3-year follow-up study is currently being conducted. The different treatment steps and options of the outpatient clinic are given in figure 1.
Outpatient Detoxification Model
The outpatient detoxification program was developed by the principal investigator (first author) and introduced into clinical practice in 1998 [for methods see, Soyka et al., 1999 Soyka et al., , 2001 .
Patients are initially seen in the outpatient clinic. Patients are referred for participation in the two-step rehabilitation program described above. Before that detoxification must have been performed either on an outpatient or inpatient basis. After detoxification patients are supposed to enter the alcohol treatment program. The time schedule of outpatient detoxification is given in figure 1 .
A major tool is the assessment of possible risk factors before treatment begin. Patients are carefully screened for major psychiatric (depression, schizophrenia, polytoxicomania, etc.) and somatic/neurologic disorders (seizures, history of alcohol psychoses) using a number of diagnostic instruments (ECG, drug screening, detailed laboratory examination).
For assessment of alcohol withdrawal the CIWA-A scale [Shaw et al., 1981; Sullivan et al., 1989 ] is used. The validated German version of the CIWA-A scale by Stuppaeck et al. [1994] is a 12-item scale which comprises following items: blood pressure (RR), pulse rate, respiratory rate, body temperature, seizures, nausea/vomiting, tremor, hyperhidrosis, tactile/auditory/visual disturbances, orientation, concentration, nervousness/anxiety and headache. In contrast to the original scale by Sullivan et al. [1989] with grades from 0 to 7 the German CIWA-A-scale uses grades from 1 (non existent) to 6 (maximum), except for seizures. The total minimum score of the scale is 11 (no symptoms).
Additionally the Alcohol Withdrawal Scale (AWS) is used [Wetterling et al., 1995a, b] . This is an 11-item scale with grades from 0 = none to 3 = severe.
Procedure
During detoxification, patients are seen on a daily basis for 5-7 (maximum 10) days. Beside somatic and psychiatric examinations, group therapy and individual motivational-oriented psychotherapy (minimum 3 h during detoxification) are offered during treatment ( fig. 2 ; see also below). Withdrawal symptoms were measured on a daily basis (CIWA-A scale, AWS scale). Patients have to give written consent before starting treatment.
In case of severe medical complications patients will be transferred to hospital, preferably the Psychiatric Hospital of the University of Munich.
Medication
Patients received vitamins (especially B1) and minerals (Na, K, Mg) if necessary. Although medication in general was given on an individualized decision basis, the literature [Mayo-Smith, 1997] and our own experience suggest that patients with a CIWA-A score of 1 16 or an AWS score of 1 6 require medication. If the patient experienced withdrawal symptoms as measured by the AWS (1 6 mean value for withdrawal symptoms) and the CIWA-A scale (1 16) pharmacotherapy was initiated.
Initially to avoid tranquilizers/hypnotics with abuse potential (benzodiazepines and chlormethiazole) a symptom-triggered pharmacological treatment either with doxepine (25-50 mg, maximum 100 mg) or clonidine (systolic hypertension, RR 1 180 mm Hg) was initiated. In leading German textbooks of clinical psychopharmacology this antidepressant is recommended for treatment of alcohol withdrawal [Benkert and Hippius, 1996] . Although no standard fixed dose regime was used the usual medication scheme in case of hypertension (1 160/100 mm Hg) was 3 ! 2!75 Ìg clonidine on days 1 and 2 and 1-3 ! 75 Ìg on day 3. Clonidine is a first-line medication for hypertension in alcohol withdrawal [for review see, Soyka et al., 1999] . For sleep disorder 25 mg doxepine was given in the evening; in case of severe agitation, restlessness or other vegetative symptomatology the dose was increased to 3 ! 25 mg doxepine. Later on during the program a combination of carbamazepine and tiapride was used for outpatient detoxification [Soyka et al., 2002] .
Motivational Psychotherapy during Detoxification
Based on the concept of Rollnick [1991, 1999] , the 3-hour motivational oriented psychotherapy during outpatient treatment aimed to motivate patient for further therapy and abstinence. In two individual sessions the patient's alcohol history and its consequences for work, health and family were addressed. The patient was advised to remain abstinent in the future, and arguments for (or against) further abstinence were balanced. In the next step the patient's personal situation and future perspectives were addressed. Possible deficits in various areas were the subject of discussion. The patient was supposed to learn that his psychosocial situation (workplace, family, finance) will benefit from further abstinence. Finally possible psychotherapeutic interventions in the post-detoxification period were outlined and possibly organized. Based on the patient's own alcohol history further alcohol therapy was initiated focusing on outpatient rehabilitation.
The motivational group therapy session had the main aim to reduce the patient's resistance to treatment and was also used as a diagnostic instrument to explore the patient's interaction with others (feedback). In the group therapy the patient could also report his personal experience with alcohol.
Follow-Up Interview
Patients were personally interviewed and examined after 12 months. Breathalyzer tests and if possible collateral information from the spouse or other family members or GPs were used to verify/ exclude abstinence. Biological parameters like Á-glutamyltransferase and carbohydrate-deficient transferrin were measured if the patient's self-report seemed to be inconsistent with the clinical findings. 
Results
Of 557 patients screened between July 1998 and June 2003, 331 (59%) entered the program. For medical reasons 223 patients had to be transferred to a hospital. Three patients decided to be detoxified by their general practitioner. Patient characteristics are given in table 1. Of the 331 patients 222 (67%) were male and 109 (33%) female. Mean age was 44.3 (24-72, SD 8.5) years, mean duration of alcohol dependence 9.8 (SD 9.0) years. The Soyka/Horak mean Á-glutamyltransferase value was 99 (SD 11.0) U/l at baseline. Mean alcohol consumption in the month prior to baseline was reported to be 156 (SD 72) g/day.
106 of 331 patients (32%) had been previously treated for alcohol dependence in a rehabilitation program. 149 of 331 (45%) had been treated as inpatients for alcohol detoxification.
Although patients were asked to reduce alcohol consumption before treatment, breathalyzer tests showed that 99 of 331 (30%) patients were still intoxicated at the begin of withdrawal (blood alcohol concentration 0.1 and 2.7).
195 (58.9%) patients received medication. Withdrawal symptoms were measured on a daily basis (13-item CIWA-A scale, AWS scale). There were no serious medical complications, especially no seizures, alcohol withdrawal delirium or other neurological disorders.
58 of 195 (30%) patients received doxepine, 68 of 195 (35%) clonidine, 29 of 195 (15%) in combination, 39 of 195 (20%) patients other medications (ß-blocker, carbamazepine/tiapride, other antidepressants).
The mean CIWA-A score on day 1 was 18.1 (13-27) which gradually declined over the treatment period ( fig. 2, 3) . The same was true for the AWS score.
Outcome
An overview of treatment outcome in patients admitted for alcohol detoxification is given in figures 4 and 5.
Of the 331 patients enrolled, 312 (94%) successfully terminated treatment. 19 (6%) patients dropped out of treatment. Reasons for dropping out were: alcohol relapse (n = 10); lack of motivation; noncompliance, or problems at work or with health insurance (n = 9).
Of the 312 patients who successfully ended outpatient detoxification, 301 (96%) entered the first motivationaloriented treatment phase at the outpatient clinic. 11 (4%) opted for psychotherapy in another facility.
12-Month Outcome
Patients were examined 12 months after outpatient detoxification by personal interview. Data of the 12-month follow-up evaluation indicate the following results. 114 (38%) patients dropped out of treatment during the first 3-month motivational treatment phase primarily because of relapse to alcohol. 48 (16%) dropped out of treatment during the consecutive 6-to 8-month rehabilitation phase, while 97 (32 %) of the 301 patients completed the rehabilitation phase without any relapse.
Discussion
While in Scandinavia, Great Britain and the US a number of treatment models for outpatient alcohol detoxification have been proposed and evaluated [Alsen, 1975; Alterman et al., 1998; Bjorkquist et al., 1976 , O'Connor et al., 1991 Webb and Unwin, 1988] , mostly in specialized outpatient clinics but partially also at home [Stockwell et al., 1986] , to date in Germany outpatient detoxification is hardly practiced, at least on a structured basis. The literature on this subject is still surprisingly limited. In 1998 Wiseman et al. reported a completion rate of 85%, a figure similar to those found in other studies [Collins et al., 1990; Alterman et al., 1998; O'Connor et al., 1991; Webb and Unwin, 1998; Stockwell et al., 1986; Hayashida et al., 1989; Stinnet, 1982; Feldman et al., 1975] . Still, little is known about the mid-and long-term efficacy of outpatient detoxification concerning abstinence and motivation of patients for further treatment.
We report results on the efficacy of an outpatient alcohol detoxification program which was launched after intensive negotiations with major health care insurances in the outer Munich area in 1998. The study was performed in an outpatient alcohol clinic which already offered a comprehensive outpatient rehabilitation program [Soyka et al., 1997] and had expressed its interest in a collaboration in this area. The results of this treatment program with a 94% completion rate of outpatient detoxification support the positive results reported by Wiseman et al. [1997 Wiseman et al. [ , 1998 ] and others [Collins et al., 1990; Alterman et al., 1998; Bjorkquist et al., 1976; , 1989] and suggest that outpatient alcohol detoxification can be considered a safe and effective treatment option for a subgroup of alcoholic patients.
There are several limitations to our study. First no control group could be studied to compare effects of outpatient vs. inpatient or the efficacy of the psychotherapeutic interventions compared to a basically somatic detoxification.
While this study was primarily designed to study the feasibility and safety of the outpatient treatment model, future research will address the mid-and long-term outcome of outpatient detoxification compared to inpatient treatment.
Second, both for inpatient and outpatient treatment of alcoholics, setting effects have to be considered [Finney et al., 1996] . Although the patients included in our sample had a long-term alcohol history, the level of psychiatric comorbidity was probably lower compared to patients seen in other detoxification wards. In other studies patients with high psychiatric severity and/or poor social support were found to benefit more from inpatient compared to outpatient treatment [Pettinati et al., 1993] .
From a methodological point of view it seems noteworthy that the treatment program evaluated in our study had been conducted in a highly structured outpatient clinic offering an intensive post-detoxification outpatient treatment rehabilitation program. Studies in less intensive outpatient settings may reveal less favorable results. The clinical management of withdrawal symptoms on an outpatient basis, including adequate dosages of appropriate medications and treatment of comorbid psychiatric or medical disorders, deserves future attention. In most of the studies quoted about hypnotics, benzodiazepines were predominantly used for treatment of withdrawal symptoms either in a fixed dosage regime [Collins et al., 1990] or on an individualized, symptom-oriented basis [Wiseman et al., 1998 ]. Other authors favor the use of anticonvulsants [Longo et al., 2002] , especially carbamazepine [Malcolm et al., 2002] . Although the effectiveness of benzodiazepines in the treatment of alcohol withdrawal symptoms has clearly been demonstrated, its use in outpatient withdrawal may be discussed and considered with caution. At least in Germany the prescription of benzodiazepines and other hypnotics such as chlormethiazole to alcoholics on an outpatient basis is controversial predominantly because of the risk of over-sedation/intoxication and the apparent abuse potential. In the program reported, doxepine and/or clonidine respectively carbamazepine/tiapride were given if necessary and the clinical impression and treatment results concerning medical complications and feasibility of treatment were quite favorable. Since this study was not primarily designed to evaluate different pharmacological regimes in outpatient detoxification, these results may be considered to be preliminary in some respects but future studies and a more detailed analysis of this continuing program may address this question in more detail.
In conclusion, the clinical results of the outpatient detoxification program presented suggest that this therapeutic approach is safe and practical. Future studies should focus on different treatment settings (outpatient clinic vs. home detoxification), individual variables predicting outcome, evaluation of different pharmacological regimes for outpatient treatment including antidepressants and carbamazepine [Bjorkquist et al., 1976 ] that might minimize the risk for secondary drug dependence and socioeconomic factors (cost-benefit ratio), among others.
